PEDIATRICS Vol. 82 No. 1 July 1988, pp. 76-82
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitchell, W. G.
Right arrow Articles by Crawford, T. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchell, W. G.
Right arrow Articles by Crawford, T. O.

Intraparenchymal Cerebral Cysticercosis in Children: Diagnosis and Treatment

Wendy G. Mitchell MD1 and Thomas O. Crawford MD1

1 From the Childrens Hospital of Los Angeles, Neurology Division, Los Angeles

Cerebral cysticercosis is being diagnosed with increasing frequency in children in the United States. A total of 52 patients with intraparenchymal cerebral cysticercosis, 21 months to 20 years of age, were observed for 2 to 72 months. Actively inflamed acute lesions, with or without coexisting chronic calcified lesions, were seen in 42 patients. Solitary lesions were seen in 39 patients, multiple lesions in 13. Chronic inactive calcified lesions were seen in ten children. A total of 51 patients had seizures that were either partial or partial with secondary generalization. Patients were treated with anticonvulsants. Praziquantel was not used. All active lesions resolved completely or with punctate calcification in 2 to 9 months, according to radiographic findings. Seizures were easily controlled. Patients were gradually weaned from anticonvulsants and in 60% no seizures recurred. Prognosis was generally good. Characteristics of the CT scans are detailed.

Key Words: intraparenchymal cerebral cysticercosis • intracranial lesion • seizure • computed tomography

Submitted on April 27, 1987
Accepted on July 15, 1987




This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
O. H. Del Brutto, K. L. Roos, C. S. Coffey, and H. H. Garcia
Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel
Ann Intern Med, July 4, 2006; 145(1): 43 - 51.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. T. Wallin and J. F. Kurtzke
Neurocysticercosis in the United States: Review of an important emerging infection
Neurology, November 9, 2004; 63(9): 1559 - 1564.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
P. Singhi and S. Singhi
Topical Review: Neurocysticercosis in Children
J Child Neurol, July 1, 2004; 19(7): 482 - 492.
[Abstract] [PDF]

Home page
 NeurologyHome page
T. E. Nash, O. H. Del Brutto, J. A. Butman, T. Corona, A. Delgado-Escueta, R. M. Duron, C. A.W. Evans, R. H. Gilman, A. E. Gonzalez, J. A. Loeb, et al.
Calcific neurocysticercosis and epileptogenesis
Neurology, June 8, 2004; 62(11): 1934 - 1938.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Carpio and W. A. Hauser
Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis
Neurology, December 10, 2002; 59(11): 1730 - 1734.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
H. H. Garcia, C. A. W. Evans, T. E. Nash, O. M. Takayanagui, A. C. White Jr., D. Botero, V. Rajshekhar, V. C. W. Tsang, P. M. Schantz, J. C. Allan, et al.
Current Consensus Guidelines for Treatment of Neurocysticercosis
Clin. Microbiol. Rev., October 1, 2002; 15(4): 747 - 756.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
O. H. Del Brutto, V. Rajshekhar, A. C. White Jr., V. C. W. Tsang, T. E. Nash, O. M. Takayanagui, P. M. Schantz, C. A. W. Evans, A. Flisser, D. Correa, et al.
Proposed diagnostic criteria for neurocysticercosis
Neurology, July 24, 2001; 57(2): 177 - 183.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
P. Singhi, M. Ray, S. Singhi, and N. Khandelwal
Clinical Spectrum of 500 Children With Neurocysticercosis and Response to Albendazole Therapy
J Child Neurol, April 1, 2000; 15(4): 207 - 213.
[Abstract] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
D. K Pal, A. Carpio, and J. W A S Sander
Neurocysticercosis and epilepsy in developing countries
J. Neurol. Neurosurg. Psychiatry, February 1, 2000; 68(2): 137 - 143.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
T. E. Nash and N. J. Patronas
Edema associated with calcified lesions in neurocysticercosis
Neurology, September 1, 1999; 53(4): 777 - 777.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
H. H. Garcia and R. H. Gilman
Medical Treatment of Cysticercosis: Ineffective vs Effective
Arch Neurol, October 1, 1995; 52(10): 941 - 941.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
A. Lowichik and A. J. Ruff
Topical Review: Parasitic Infections of the Central Nervous System in Children. Part III: Space-Occupying Lesions
J Child Neurol, May 1, 1995; 10(3): 177 - 190.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
O. H. Del Brutto
Medical Treatment of Cysticercosis--Effective
Arch Neurol, January 1, 1995; 52(1): 102 - 104.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
O. H. D. Brutto, J. Sotelo, R. Aguirre, E. Diaz-Calderon, and T. A. Alarcon
Albendazole Therapy for Giant Subarachnoid Cysticerci
Arch Neurol, May 1, 1992; 49(5): 535 - 538.
[Abstract] [PDF]